Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
Acta Radiologica (Stockholm, Sweden : 1987)
|
January 22, 2010
Revascularization of traumatic renal artery dissection by endoluminal stenting: three cases
Pascal Chabrot, Lucie Cassagnes, Agaïcha Alfidja, et al.
Journal of Surgical Oncology
|
October 30, 2015
Previous radiation for prostate neoplasm alters surgical and oncologic outcomes after rectal cancer surgery
Marlène Guandalino, Aurélien Dupré, Marie François, et al.
In Vivo (Athens, Greece)
|
October 25, 2011
miRNAs differentially expressed in prostate cancer cell lines after soy treatment
Nadège Rabiau, Hibatullahi-Kauthar Trraf, Mawussi Adjakly, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 27, 2014
Efficacy and tolerance of one-third full dose bacillus Calmette-Guérin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study
Christian Pfister, Walid Kerkeni, Jerome Rigaud, et al.
Future Oncology (London, England)
|
February 5, 2021
Apalutamide, darolutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer: a meta-analysis
Mathieu Roumiguié, Xavier Paoletti, Yann Neuzillet, et al.
Urology
|
January 31, 2006
Randomized Phase II study comparing paclitaxel and carboplatin versus mitoxantrone in patients with hormone-refractory prostate cancer
Aurélie Cabrespine, Laurent Guy, Elhani Khenifar, et al.
European Urology
|
September 2, 2020
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses
Christian Pfister, Gwenaelle Gravis, Aude Fléchon, et al.
Oncology Reports
|
June 14, 2011
BRCA1, BRCA2, AR and IGF-I expression in prostate cancer: correlation between RT-qPCR and immunohistochemical detection
Nadège Rabiau, Pierre Déchelotte, Mawussi Adjakly, et al.
Nutrition and Cancer
|
March 20, 2014
Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines
Mawussi Adjakly, Marjolaine Ngollo, André Lebert, et al.
Endocrinology
|
May 2, 2012
Lxrα regulates the androgen response in prostate epithelium
Emilie Viennois, Teresa Esposito, Julie Dufour, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
Acta Radiologica (Stockholm, Sweden : 1987)
|
January 22, 2010
Revascularization of traumatic renal artery dissection by endoluminal stenting: three cases
Pascal Chabrot, Lucie Cassagnes, Agaïcha Alfidja, et al.
Journal of Surgical Oncology
|
October 30, 2015
Previous radiation for prostate neoplasm alters surgical and oncologic outcomes after rectal cancer surgery
Marlène Guandalino, Aurélien Dupré, Marie François, et al.
In Vivo (Athens, Greece)
|
October 25, 2011
miRNAs differentially expressed in prostate cancer cell lines after soy treatment
Nadège Rabiau, Hibatullahi-Kauthar Trraf, Mawussi Adjakly, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 27, 2014
Efficacy and tolerance of one-third full dose bacillus Calmette-Guérin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study
Christian Pfister, Walid Kerkeni, Jerome Rigaud, et al.
Future Oncology (London, England)
|
February 5, 2021
Apalutamide, darolutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer: a meta-analysis
Mathieu Roumiguié, Xavier Paoletti, Yann Neuzillet, et al.
Urology
|
January 31, 2006
Randomized Phase II study comparing paclitaxel and carboplatin versus mitoxantrone in patients with hormone-refractory prostate cancer
Aurélie Cabrespine, Laurent Guy, Elhani Khenifar, et al.
European Urology
|
September 2, 2020
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses
Christian Pfister, Gwenaelle Gravis, Aude Fléchon, et al.
Oncology Reports
|
June 14, 2011
BRCA1, BRCA2, AR and IGF-I expression in prostate cancer: correlation between RT-qPCR and immunohistochemical detection
Nadège Rabiau, Pierre Déchelotte, Mawussi Adjakly, et al.
Nutrition and Cancer
|
March 20, 2014
Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines
Mawussi Adjakly, Marjolaine Ngollo, André Lebert, et al.
Endocrinology
|
May 2, 2012
Lxrα regulates the androgen response in prostate epithelium
Emilie Viennois, Teresa Esposito, Julie Dufour, et al.
Page
of 9